ECG AI-Guided Screening for Low Ejection Fraction (EAGLE)

Mayo Clinic

Status: Completed

Conditions: Heart Failure; Asymptomatic Left Ventricular Systolic Dysfunction (Disorder)

Treatments: Other: AI-enabled ECG-based Screening Tool

Study type: Interventional

Funder types: Other

Identifiers

NCT04000087

19-003137

Details and patient eligibility

About

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.

Enrollment: 358 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Primary care clinicians who are part of a participating care team that care for adult patients and have the ability to order ECG and TTE (this includes physicians, nurse practitioners, and physician assistants).

Exclusion criteria

• Primary care clinicians working in pediatrics, acute care, nursing homes, and resident care teams.

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

358 participants in 2 patient groups

Intervention

Experimental group

Description:

Care teams randomized to intervention will have access to the screening tool.

Treatment:

Other: AI-enabled ECG-based Screening Tool

Control

No Intervention group

Description:

Care teams randomized to control will continue routine practice.